Prazitone

This MedLibrary.org supplementary page on Prazitone is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Prazitone
Systematic (IUPAC) name
5-phenyl-5-(piperidin-2-ylmethyl)-1,3-diazinane-2,4,6-trione
Identifiers
CAS number 2409-26-9
ATC code  ?
PubChem 3050417
Chemical data
Formula C16H19N3O3 
Mol. mass 301.34 g/mol
Synonyms Prazitone, AGN-511, 5-Phenyl-5-(2-piperidylmethyl)barbituric acid
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Prazitone (AGN-511) is a barbiturate derivative invented in the 1970s. Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.[1] The dosage range in humans is around 200-600mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.

References

  1. ^ Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596

Wikipedia content modification information:

  • This page was last modified on 14 June 2008, at 08:37.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Prazitone".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.